Cipla Q4 Profit Jumps 30% to ₹1,222 Crore, Special Dividend Announced
| 2025-05-14
Cipla reported a 30% year-on-year rise in net profit for the fourth quarter, reaching ₹1,222 crore, driven by strong performance in India and select global markets.
Cipla reports 30% rise in Q4 profit to ₹1,222 crore and announces a special dividend, marking its 90th anniversary. Revenue up 9% year-on-year.
Cipla Reports Strong Q4 Profit Growth, Declares Special Dividend for 90th Anniversary
Indian pharmaceutical company Cipla has reported a 30% rise in consolidated net profit for the fourth quarter of the financial year ending March 2025, reaching ₹1,222 crore. The company also announced a special dividend to commemorate its 90th anniversary.
According to a filing with Indian stock exchanges on Tuesday, the company’s Q4 net profit rose sharply from ₹939 crore reported during the same period last year. However, on a sequential basis, profit declined 22% from ₹1,570 crore in the previous quarter.
Revenue and Market Performance
Cipla’s consolidated revenue from operations increased 9% year-on-year to ₹6,730 crore in the March quarter, compared to ₹6,163 crore in the same period last year. Sequentially, revenue slipped 5% from ₹7,073 crore posted in the December quarter.
The company’s earnings before interest, tax, depreciation, and amortisation (EBITDA) rose 16.8% year-on-year to ₹1,537 crore, with the EBITDA margin improving to 22.84% from 21% a year ago.
Despite the improved annual performance, Cipla's shares remained largely stable following the results announcement. The stock closed 0.49% higher at ₹1,519.45 on the Bombay Stock Exchange on Tuesday.
Segment Performance and International Markets
Cipla's performance in international markets showed mixed results. Revenue from the United States—its largest overseas market—declined slightly to $221 million, down from $226 million in the same quarter last year. In contrast, sales in other regions grew, with revenue from Africa increasing 20% to ₹1,019 crore. Domestic revenue also rose 8% year-on-year to ₹2,622 crore, while North America sales in Indian rupee terms increased 2% to ₹1,919 crore.
Annual Results and Strategic Outlook
For the full financial year (FY25), Cipla reported a 28% increase in consolidated net profit, reaching ₹5,273 crore, compared to ₹4,122 crore the previous year. Revenue from operations for the year rose by 7% to ₹27,548 crore.
In a statement accompanying the results, Cipla’s Managing Director and Global Chief Executive Officer Umang Vohra said: “Going ahead, the focus will be on growing our key markets, further building our flagship brands, investing in future pipeline as well as focusing on resolutions on the regulatory front.”
Dividend Announcement Marks Milestone Year
To mark its 90th year of operations, Cipla’s Board of Directors has recommended a final dividend of ₹13 per share and a special dividend of ₹3 per share, bringing the total proposed dividend to ₹16 per share. The face value of each share is ₹2. If approved by shareholders, the dividend will be paid within 30 days following the company’s Annual General Meeting.
Context: Cipla’s Position in the Global Pharmaceutical Industry
Founded in 1935 and headquartered in Mumbai, Cipla is one of India’s oldest and largest pharmaceutical companies, with a significant presence in generics and active pharmaceutical ingredients (APIs). The firm has a diversified global footprint, with operations across North America, Africa, and key emerging markets.
The latest results reflect not only Cipla's resilience in a competitive global pharmaceutical landscape but also the company’s strategic emphasis on expanding its core product lines and maintaining regulatory compliance in key markets.
As the company enters its 91st year, its leadership has signalled ongoing investment in research and development and a continued focus on branded generics to sustain growth across geographies.
India Approves Rs 3,700 Crore Semiconductor Plant in Uttar Pradesh
India's Cabinet has cleared a Rs 3,700 crore HCL-Foxconn semiconductor plant in Uttar Pradesh to produce display driver chips, boosting domestic chip manufacturing.
|2025-05-14
India's Outward FDI Rises to $6.8 Billion in April, RBI Data Shows
India’s foreign investment abroad nearly doubles year-on-year, led by equity and guarantees
|2025-05-14
India and Austria Denounce Nuclear Blackmail Amid Regional Tensions
India and Austria have jointly opposed nuclear blackmail during a diplomatic call, as tensions escalate between India and Pakistan following cross-border clashes.
|2025-05-14
India Expels Pakistani Diplomat Declared Persona Non Grata Amid Tensions
India orders Pakistani High Commission official to leave within 24 hours, citing conduct incompatible with diplomatic status amid heightened India-Pakistan tensions.
|2025-05-14
Bharti Airtel Q4 Profit Surges 432% to ₹11,022 Crore on Tariff Hikes
Bharti Airtel reports a 432% rise in Q4 net profit to ₹11,022 crore, driven by tariff hikes, subscriber growth, and India momentum; revenue up 27% YoY.
|2025-05-14